Burmester, G. R., Matucci-Cerinic, M., Mariette, X., Navarro-Blasco, F., Kary, S., Unnebrink, K., & Kupper, H. (2014). Safety and effectiveness of adalimumab in patients with rheumatoid arthritis over 5 years of therapy in a phase 3b and subsequent postmarketing observational study. BioMed Central.

Burmester, Gerd R., Marco Matucci-Cerinic, Xavier Mariette, Francisco Navarro-Blasco, Sonja Kary, Kristina Unnebrink, and Hartmut Kupper. Safety and Effectiveness of Adalimumab in Patients With Rheumatoid Arthritis Over 5 Years of Therapy in a Phase 3b and Subsequent Postmarketing Observational Study. BioMed Central, 2014.

Burmester, Gerd R., et al. Safety and Effectiveness of Adalimumab in Patients With Rheumatoid Arthritis Over 5 Years of Therapy in a Phase 3b and Subsequent Postmarketing Observational Study. BioMed Central, 2014.